Analysts think ILMN stock price could increase by 67%
Mar 08, 2025, 12:25 PM
-14.40%
What does ILMN do
Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
26 analysts think ILMN stock price will increase by 67.18%. The current median analyst target is $144.89 compared to a current stock price of $86.67. The lowest analysts target is $90.90 and the highest analyst target is $259.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.